Under physiological conditions, PD-L1/PD-1 is a synergistic inhibitory signaling pathway in which PD-L1 binds to the receptor PD-1 on activated T cells, maintaining peripheral tolerance and immune homeostasis in T cells, thereby preventing T cell over-activation to avoid autoimmune disease [8]. The gene discussed is CD274; the disease is autoimmune disease.